Annals of Neurology

Botox may reduce chronic neuropathic pain

(HealthDay)—Subcutaneous botulinum toxin type A (BTX-A) injections appear to safely and effectively reduce chronic neuropathic pain in patients with spinal cord injury, according to a study published online Jan. 27 in the ...

Feb 09, 2016
popularity48 comments 0

Predicting who will develop multiple sclerosis

A team of investigators at Brigham and Women's Hospital (BWH) and the National Institute of Neurological Disorders and Stroke (NINDS) has launched a study of individuals at risk for multiple sclerosis (MS). By focusing on ...

Feb 08, 2016
popularity40 comments 0